Drug Interactions With Cyclosporine-Rifampicin-Clarithromycin in a Kidney Transplant Recipient With Mycobacterium Malmoense

Ana Aldea Perona, Mar García Sáiz, Lourdes Pérez Tamajón

Abstract


A 38-year-old kidney transplant recipient was treated with antituberculous drugs due to mycobacterial joint infection due to Mycobacterium malmoense. Three days of starting combined therapy, cyclosporine blood concentration (CBC) decreased a 63% and was necessary to increase the cyclosporine dose. Clarithromycin was also added and the CBC and kidney function remained stable until 11 months later. Pirazinamide and isoniazide were withdrawn four months before without any analytical changes but when rifampicin and ethambutol were withdrawn, CBC showed an increase of 377% and creatinine level was worsened. It was necessary to reduce the cyclosporine dose and renal function improved within 6 weeks. When clarithromycin was discontinued, the CBC decreased a 69% which motivated gradually increasing the dose. CBC is liable to change in patients treated with drugs metabolized by cytochrome p450 system, and the effect and magnitude of a multiple interaction is unpredictable. Close monitoring is necessary to adjust the dosage.




J Med Cases. 2013;4(4):227-229
doi: https://doi.org/10.4021/jmc1058w

Keywords


Cyclosporine; Kidney transplantion; Antitubercular agents; Mycobacterium malmoense; Tuberculosis osteoarticular

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org    elmer.editorial@hotmail.com
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.